OR WAIT null SECS
January 11, 2018
The company will use funding from the Bill & Melinda Gates Foundation to develop a new production method for artemisinin, a therapeutic used to treat malaria.
December 28, 2017
Mallinckrodt has agreed to acquire biopharmaceutical company Sucampo Pharmaceuticals for $18 per share, or a transaction value of approximately $1.2 billion.
Roche has agreed to acquire Ignyta, an oncology company specializing in precision medicines, in an all-cash transaction valued at $1.7 billion.
December 18, 2017
The agency published guidance on the research and development of individualized therapies.
December 15, 2017
Research into an old antibiotic might open the door for new drugs to treat tuberculosis and other related microbial diseases.
December 14, 2017
Children with a rare brainstem-based cancer might be helped by a new immunotherapy that targets a mutated protein found exclusively in cancer cells.
December 08, 2017
Gilead Sciences will acquire Cell Design Labs to further cell-therapy research and development efforts.
December 02, 2017
New gene therapies and combination products require innovative regulatory approaches.
November 29, 2017
Biocad and Sothema Labs have partnered to release cancer-treating biosimilars into the North African market.
November 27, 2017
The new guidelines discuss GMPs and patient protection specific to advanced therapy medicinal products.